KDR and brain glioma: The presented methods for determining the tested cytokines (VEGF-A, VEGF-R2, and FGF-2) could be used primarily to differentiate benign grades of brain glioma from malignant grades, while the VEGF-A method could be used for the diagnosis of ALL.